Blog

Blog

By Kevin Hrusovsky, President, Chairman and CEO Quanterix

February often makes us reflect upon our hearts. For some, it’s the trials and tribulations of love, with Valentine’s Day just recently passing us by. However, for many others, battles with the heart have much graver consequences, with heart disease remaining the leading cause of death worldwide.

By Kevin Hrusovsky, President, Chairman and CEO Quanterix

The 36th annual J.P Morgan Healthcare conference took over San Francisco earlier this month. With more than 10,000 attendees, representing more than 450 private and public companies, the event is the largest healthcare investment symposium in the industry. This year’s event was keynoted by leading industry executives, including Bill Gates. Bill inspired the attendees as he showcased some of the accomplishments that the Bill & Melinda Gates Foundation has achieved this year, including progress lowering child mortality rates and combating diseases that disproportionately affect people in developing and third world countries.

By Kevin Hrusovsky, President, Chairman and CEO Quanterix

2018 will be a year dedicated to pushing the envelope in ways that are outrageously imaginative, ambitious, and impactful. It takes boldness to change the world, and that’s the exact approach we are taking with our Precision Health movement; a movement that is galvanizing around a new paradigm of a personalized, pro-active approach to medicine that emphasizes maintenance of wellness, the earliest possible disease detection, and precision drug therapy vs. reacting to overt symptoms.

By Kevin Hrusovsky, Executive Chairman and CEO, Quanterix

As the National Institutes of Health continues to push its “All of Us” Research Program forward – an ambitious effort to gather data for over a million people living in the U.S to accelerate precision medicine research – medical professionals are also banding together to advance the science of precision health at the Powering Precision Health Summit (PPHS). After launching the conference last year, we are expecting that PPHS 2017 will be even bigger and more impactful, with over 500 attendees from around the world.

By Kevin Hrusovsky, Executive Chairman and CEO, Quanterix

There was a thrilling energy in the air at last year’s Powering Precision Health Summit (PPHS) – a feeling that could only come from the sense of community and empowerment we experienced at the inaugural event. As the world’s first innovation-driven summit dedicated to transforming precision health, PPHS brought together key stakeholders across the healthcare community, including physicians, scientists, innovators, biopharma executives, patients and patient advocates, to tackle the world’s most pressing issues, as we move forward on the path to turn today’s reactive sick care into tomorrow’s preventative health care.